Efficacy and safety of interferon alfa-2b and ribavirin combination therapy in chronic hepatitis C patients: A Czech multicenter study

被引：0
|
作者：
Husa, P
Krtek, V
Svejda, J
Stransky, J
Cieslarova, B
Nadvornik, V
Ehrmann, J
Urbanek, P
Volfova, M
机构：
[1] Teaching Hosp, Brno, Czech Republic
[2] Teaching Hosp, Krc, Czech Republic
[3] Private Doctors Assoc, Usti Nad Labem, Czech Republic
[4] Teaching Hosp Kralovske Vinohadry, Prague, Czech Republic
[5] Mil Hosp, Prague, Czech Republic
[6] Teaching Hosp, Olomouc, Czech Republic
[7] Teaching Hosp Praha 2, Prague, Czech Republic
[8] Teaching Hosp, Hradec Kralove, Czech Republic
来源：
JOURNAL OF HEPATOLOGY | 2002年 / 36卷
关键词：
D O I：
10.1016/S0168-8278(02)80849-2
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
848
引用
收藏
页码：237 / 237
页数：1
相关论文
共 50 条
  • [31] Induction therapy of interferon alfa-2b in combination with ribavirin as initial treatment for chronic hepatitis C genotype 1: A pilot study
    Palisoc, Alma M.
    Fayad, Joseph
    Singh, Ashok K.
    Farnham, Irene M.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (09): : S164 - S164
  • [32] Effectiveness and tolerability of pegylated interferon alfa-2b in combination with ribavirin for treatment of chronic hepatitis C : the PegIntrust Study
    Van Vlierberghe, H.
    Adler, M.
    Bastens, B.
    Colle, I.
    Delwaide, J.
    Henrion, J.
    Horsmans, Y.
    Michielsen, P.
    Golstein, P.
    Mulkays, J. -P.
    Van Steenbergen, W.
    Yap, P.
    Nevens, F.
    Denys, A. M.
    Brasseur, J. -P.
    ACTA GASTRO-ENTEROLOGICA BELGICA, 2010, 73 (01) : 5 - 11
  • [33] Peginterferon alfa-2b plus ribavirin versus interferon alfa-2b plus ribavirin for chronic hepatitis C in HIV-coinfected patients
    Crespo, M
    Sauleda, S
    Esteban, JI
    Juarez, A
    Buti, M
    Pahissa, A
    Esteban, R
    Guardia, J
    HEPATOLOGY, 2005, 42 (04) : 701A - 702A
  • [34] Pegylated interferon alfa-2b plus ribavirin in patients with chronic hepatitis C: A trial in prior nonresponders to interferon monotherapy or combination therapy and in combination therapy relapsers.
    Jacobson, I
    Russo, MW
    Brown, RS
    Lebovics, E
    Min, A
    Esposito, S
    Tobias, H
    Klion, F
    Rovner, D
    Brass, C
    HEPATOLOGY, 2002, 36 (04) : 358A - 358A
  • [35] Interferon alfa 2b and ribavirin combination therapy for patients with chronic viral hepatitis C failing interferon therapy
    Galica, M
    Alhajjar, B
    Salen, G
    Dyrszka, H
    Sanghavi, B
    Eskreis, D
    HEPATOLOGY, 1998, 28 (04) : 709A - 709A
  • [36] Pegylated interferon alfa-2b plus ribavirin in patients with chronic hepatitis C: A trial in prior nonresponders to interferon monotherapy or combination therapy, and in combination therapy relapsers.
    Jacobson, IM
    Russo, MW
    Brown, RS
    Lebovics, E
    Min, A
    Esposito, S
    Tobias, H
    Klion, F
    Pizov, O
    Brass, C
    HEPATOLOGY, 2001, 34 (04) : 338A - 338A
  • [37] Consensus Interferon and Ribavirin in Patients with Chronic Hepatitis C Who Were Nonresponders to Pegylated Interferon alfa-2b and Ribavirin
    Carroll B. Leevy
    Digestive Diseases and Sciences, 2008, 53 : 1961 - 1966
  • [38] Daily or three times a week interferon alfa-2b in combination with ribavirin or interferon alone for the treatment of patients with chronic hepatitis C
    de Lédinghen, V
    Trimoulet, P
    Winnock, M
    Foucher, J
    Bourlière, M
    Desmorat, H
    Canva, V
    Capron, D
    Lévy, S
    Mion, F
    Mannant, PR
    Chêne, G
    Fleury, H
    Couzigou, P
    Bernard, PH
    JOURNAL OF HEPATOLOGY, 2002, 36 (05) : 672 - 680
  • [39] Consensus interferon and ribavirin in patients with chronic hepatitis c who were nonresponders to pegylated interferon alfa-2b and ribavirin
    Leevy, Carroll B.
    DIGESTIVE DISEASES AND SCIENCES, 2008, 53 (07) : 1961 - 1966
  • [40] Consensus Interferon and Ribavirin in Patients with Chronic Hepatitis C Who Were Nonresponders to Pegylated Interferon alfa-2b and Ribavirin
    Carroll B. Leevy
    Digestive Diseases and Sciences, 2008, 53 (7) : 2009 - 2009
12345